Safety and Efficacy of Duloxetine in the Treatment of Diabetic Peripheral Neuropathic Pain in Older Patients

By  

Current Drug Safety, Vol. 4, Iss. 1, 2009-01 ,pp. : 22-29

Bentham Science Publishers

Access to resources Recommend Favorite

Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial

By Frakes E.P.   Risser R.C.   Ball T.D.   Hochberg M.C.   Wohlreich M.M.  

Current Medical Research and Opinion, Vol. 27, Iss. 12, 2011-12 ,pp. : 2361-2372

Informa Healthcare

Access to resources Recommend Favorite

Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK

By Beard S. M.   McCrink L.   Le T. K.   Garcia-Cebrian A.   Monz B.   Malik R. A.  

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 385-399

Informa Healthcare

Access to resources Recommend Favorite

Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis

By Crucitti Antonio   Zhang Qi   Nilsson Mary   Brecht Stephan   Yang Charles R.   Wernicke Joachim  

Current Medical Research and Opinion, Vol. 26, Iss. 11, 2010-11 ,pp. : 2579-2588

Informa Healthcare

Access to resources Recommend Favorite

Treatment of chronic diabetic lower leg ulcers with activated protein C: a randomised placebo‐controlled, double‐blind pilot clinical trial

By  

INTERNATIONAL WOUND JOURNAL, Vol. 12, Iss. 4, 2015-08 ,pp. : 422-427

John Wiley & Sons Inc

Access to resources Recommend Favorite